4//SEC Filing
Pauza Charles David 4
Accession 0002018150-25-000004
CIK 0001130598other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:16 PM ET
Size
7.3 KB
Accession
0002018150-25-000004
Insider Transaction Report
Form 4
Pauza Charles David
Chief Science Officer Virology
Transactions
- Award
Common Stock
2025-12-12+18,471→ 115,971 total - Award
Stock Option (right to purchase)
2025-12-12+73,886→ 73,886 totalExercise: $2.33From: 2026-12-12Exp: 2035-12-12→ Common Stock (73,886 underlying)
Footnotes (2)
- [F1]Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis.
- [F2]The options vest 100% on the first anniversary of the grant date.
Documents
Issuer
Traws Pharma, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0002018150
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:16 PM ET
- Size
- 7.3 KB